Seattle-based cancer immunotherapy company Juno Therapeutics handily beat analyst expectations for the fourth quarter, posting $21.2 million in revenue, compared to… Read More
Silverback Therapeutics, a stealthy biotech startup co-founded by investor, entrepreneur and University of Washington neurosurgery professor Peter Thompson, has raised $10… Read More
Scientific journals aren’t known for being advocates of open access — often research articles published in journals are behind a paywall, only… Read More
There is an almost overwhelming number of pressing global health issues today. Preparing for epidemics like Ebola, the increasing dangers of… Read More